Amgen Inc.
์๊ฐ์ด์ก
$226.3B
๊ธ๋ก๋ฒ ์์
#66
์ญ๋ ์ต๊ณ ์น
$226.3B
2026-08-17
์ด ์ฑ์ฅ๋ฅ
+0%
2026๋ ์ดํ
Market Cap Context
- Larger than 82% of the 367 companies we track (globally).
- Equivalent to 0.7% of United States's GDP (2025 data).
- Just above: #65 ๋ค์ฌ๋ ($226.8B)
- Just below: #67 ์ํํธ๋ฑ ํฌ ๊ทธ๋ฃน ($224.7B)
- Best year: 1999 (+130%). Worst year: 2007 (-32%).
Amgen Inc. Financial Breakdown (FY 2025)
Source: Yahoo Finance โ AMGN annual filings (2025) โ$36.8B revenue ยท $9.1B operating income ยท $7.7B net income
- โOperating margin: 24.7% on $36.8B in revenue.
- โR&D is 19.8% of revenue ($7.3B).
- โNet income margin: 21.0% โ $7.7B in profit.
- โFree cash flow: $8.1B (22.0% of revenue).
Cost / Operating Expenses
Total operating expenses $27.7B
Total
$26.4B
Capital Expenditures
$1.9B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$8.1B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Amgen Inc. ์๊ฐ
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
Amgen Inc. ์๊ฐ์ด์ก ์ถ์ด (2026โ2026)
Amgen Inc. vs Sector Peers by Market Cap
Amgen Inc. ๋น๊ต
์์ ์ถ์ด
| ์ฐ๋ | ์๊ฐ์ด์ก | ์์ | ์ ๋ ๋๋น ๋ณํ |
|---|---|---|---|
| 2026 | $226.3B | #66(โ16) | +30.0% |
| 2025 | $174.1B | #82(โ15) | +29.7% |
| 2024 | $134.3B | #97(โ27) | -6.8% |
| 2023 | $144.0B | #70(โ4) | +13.5% |
| 2022 | $126.9B | #66(โ30) | +20.4% |
| 2021 | $105.4B | #96(โ18) | +0.9% |
| 2020 | $104.5B | #78(โ13) | -2.0% |
| 2019 | $106.6B | #65(โ9) | +27.6% |
| 2018 | $83.6B | #56(โ12) | +15.2% |
| 2017 | $72.5B | #68(โ1) | +22.3% |
| 2016 | $59.3B | #69(โ12) | -7.6% |
| 2015 | $64.2B | #57(โ1) | +4.0% |
| 2014 | $61.7B | #58(โ14) | +42.3% |
| 2013 | $43.4B | #72(โ6) | +34.8% |
| 2012 | $32.2B | #78(โ8) | +36.8% |
| 2011 | $23.5B | #86(โ28) | +18.2% |
| 2010 | $19.9B | #114(โ22) | -3.0% |
| 2009 | $20.5B | #92(โ27) | -2.0% |
| 2008 | $20.9B | #65(โ68) | +24.4% |
| 2007 | $16.8B | #133(โ58) | -32.0% |
| 2006 | $24.7B | #75(โ23) | -13.4% |
| 2005 | $28.6B | #52(โ7) | +22.9% |
| 2004 | $23.2B | #59(โ7) | +3.8% |
| 2003 | $22.4B | #52(โ3) | +27.8% |
| 2002 | $17.5B | #49(โ7) | -14.4% |
| 2001 | $20.4B | #56(โ2) | -11.7% |
| 2000 | $23.2B | #58(โ8) | +6.5% |
| 1999 | $21.8B | #50(โ13) | +129.8% |
| 1998 | $9.5B | #63(โ27) | +93.2% |
| 1997 | $4.9B | #90(โ17) | -0.5% |
| 1996 | $4.9B | #73(โ19) | -8.4% |
| 1995 | $5.4B | #54(โ8) | +101.3% |
| 1994 | $2.7B | #62 |
๊ธฐํ ํฌ์ค์ผ์ด ๊ธฐ์
์์ฃผ ๋ฌป๋ ์ง๋ฌธ
What is Amgen Inc.'s market cap?
Amgen Inc. (AMGN) has a market capitalization of $226.3B, making it the #66 largest company in the world by market cap.
What was Amgen Inc.'s highest market cap?
Amgen Inc.'s all-time high market cap was $226.3B, reached in 2026-08-17. Its highest rank was #66 in 2026.
What sector is Amgen Inc. in?
Amgen Inc. is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in United States.
How has Amgen Inc.'s market cap changed over time?
Amgen Inc. has been tracked since 2026. Its market cap has grown by 0% from $226.3B in 2026 to $226.3B today.